Key Medicine Shortages for April 2022
Key Medicine Shortages – April 2022
Posted: Friday, April 1, 2022
Category - Medicines Update
Medicines Update -2022
GGC Medicines Update is a series of blogs with important medicines related messages relevant to all healthcare professionals across GGC.
- Subscribe to our blog via email:ggc.medicines.update@nhs.scot
- Follow us on Twitter
Please note, Medicines Update blogs are correct at the time of publication.
Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact ggc.medicines.update@nhs.scot.
Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC responsible for the development of Medicines Update.
If you would like to contribute to Medicines Update, click here for a guide to blog writing. When you email the committee to discuss writing a blog, you will be sent a checklist to complete prior to submitting the blog for review.
Guideline News February 2022
Posted: Thursday, March 10, 2022
Category - Medicines Update
MHRA Drug Safety Update February 2022
Posted: Tuesday, March 8, 2022
Category - Medicines Update
MHRA Drug Safety Update for February 2022
Penicillin Allergy
Posted: Monday, February 28, 2022
Category - Medicines Update
Key Medicine Shortages – March 2022
Posted: Monday, February 28, 2022
Category - Medicines Update
Key Medicine Shortages for March 2022
New Shared Care Agreement: Methotrexate for Dermatology Indications
Posted: Wednesday, February 23, 2022
Category - Medicines Update
A new Shared Care Agreement (SCA) for subcutaneous methotrexate has been approved for use in adult patients with psoriasis or eczema and other inflammatory skin conditions.
VSL#3 & Vivomixx removed from Drug Tariff
Posted: Wednesday, February 16, 2022
Category - Medicines Update
Following a review by the Advisory Committee on Borderline Substances (ACBS) back in 2018, the probiotic food supplements VSL#3® and Vivomixx® were removed from Part XV of the Drug Tariff in England. The Committee concluded that the evidence did not sufficiently demonstrate that the products are clinically effective.
Delirium: Medication Review in Acute
Posted: Monday, February 14, 2022
Category - Medicines Update
The NHSGGC Delirium Diagnosis, Risk Reduction and Management in Acute Services guideline recommends undertaking a medication review. This blog provides advice on how to undertake a medication review using the TIME structure.
Guideline News January 2022
Posted: Monday, February 14, 2022
Category - Medicines Update
Clinical Governance Related Publications Update for January 2022
Key Medicine Shortages – February 2022
Posted: Friday, February 4, 2022
Category - Medicines Update
Key Medicine Shortages for February 2022